In this report, the term "effectiveness" refers strictly to how the product's marketing language describes potential outcomes. It does not indicate that the finished product has been clinically proven ...

As the first commercially available wireless detector array for particle therapy PSQA, MatriXX AiR simplifies setup, reduces QA time, and integrates easily into existing workflows. The system is also ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has ...

A 2026 informational overview of how Purisaki Deep Cleansing Foot Pads are described in company materials — including the 2-in-1 detoxification and vitamin infusion positioning, ingredient research ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

An informational report based on materials provided by MetaFit Pharma Solutions LLC detailing how the TrimRx telehealth platform presents its GLP-1 medication options, compounded and FDA-approved ...

GLP-1 telehealth platforms, including how commonly searched topics such as "claims evaluated" and "safety risks assessed" relate to publicly available company information, FDA communications, and ...

Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, ...

An informational report compiling GaraHerb's publicly available product materials, ingredient-level research references, formulation transparency considerations, and consumer details for 2026 Aurora, ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that an ePoster ...

This event will host a critical forum where Italian-American scientist Dario Crosetto has submitted a 500-word abstract and 2-page summary detailing a breakthrough in radiation signal detection. A ...

Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment. TOKYO and CAMBRIDGE, Mass., March 20, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, ...